Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells

89Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have identified a transmembrane collagen, collagen XXIII, in rat prostate carcinoma cells. Differential display of mRNA expression in prostate carcinoma sublines with varying metastatic potential revealed overexpression of this transcript in the metastatic AT6.1 subline. cDNA cloning identified a 2733-bp transcript from AT6.1 RNA, encoding a protein of 532 amino acids, together with a 3067-bp human homologue, resulting in a 540-amino acid protein. Collagen XXIII is predicted to be a type II membrane protein consisting of an amino-terminal cytoplasmic domain, a transmembrane region, and three collagenous domains flanked by short noncollagenous domains. Collagen XXIII is a new member of the transmembrane collagen family, showing structural homology with the transmembrane collagens XIII and XXV. We present evidence that collagen XXIII is expressed as a ∼75-kDa protein at the cell surface and that it can be cleaved by furin protease activity. Cleavage results in a ∼60-kDa soluble protein that forms a multimeric complex and exhibits a low affinity interaction with heparin.

Cite

CITATION STYLE

APA

Banyard, J., Bao, L., & Zetter, B. R. (2003). Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. Journal of Biological Chemistry, 278(23), 20989–20994. https://doi.org/10.1074/jbc.M210616200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free